{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:22:45Z","timestamp":1787858565302,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The human ovary is the target of autoimmune attack in cases of autoimmune disorders, which can cause ovarian dysfunction. Due to the higher prevalence of Hashimoto\u2019s Thyroiditis (HT) in Polycystic Ovary Syndrome (PCOS) patients, we aimed to evaluate ovarian reserve and the effect of autoimmune exposure time on ovarian reserve in PCOS patients with HT by Anti-M\u00fcllerian hormone (AMH) levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Forty-six PCOS patients and 46 PCOS with HT diagnosed patients who are between 18 and 35\u2009years old were recruited for this study. Detailed medical histories were obtained from all participants. Polycystic ovary image was evaluated and antral follicles were counted by transvaginal ultrasound. Modified Ferriman Gallwey score, body mass index, waist\/hip ratio of the patients were examined. Hormonal, biochemical profiles and AMH levels of the patients were evaluated during the early follicular phase. The data of both groups were statistically analyzed with SPSS 18.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      20 (43.5%) patients in the PCOS group were fertile, 8 (17.4%) patients in the PCOS + HT group were fertile, fertility rate was significantly lower in PCOS + HT group. The mean AMH value was 8.8\u2009\u00b1\u20098.8 in the PCOS + HT group and 12.4\u2009\u00b1\u20098.1 in the PCOS group and it was significantly lower in the PCOS + HT group (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.043). AMH values were significantly negatively correlated with anti-thyroid peroxidase antibody (anti-TPO) level and the duration of HT. There was a significant positive correlation between the anti-TPO level and the duration of HT.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclus\u0131on<\/jats:title>\n                    <jats:p>We pointed out that the coexistence of PCOS and HT, two prevalent diseases of reproductive age, further diminished ovarian reserve. More exposure of the ovaries to autoantibodies can cause ovarian destruction, similar to the thyroid gland like HT. Because of all these close relations with PCOS and thyroid dysfunctions, we recommend evaluating both thyroid autoantibodies and hormone levels in PCOS patients at the first visit. Patients with PCOS + HT should be monitored more closely to determine the fertility treatment options and control premature ovarian failure (POF) table.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-021-00706-9","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T03:02:59Z","timestamp":1615258979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Hashimoto\u2019s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-M\u00fcllerian hormone levels"],"prefix":"10.1186","volume":"21","author":[{"given":"Aliye Nigar","family":"Serin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zer","family":"Birge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcheyla","family":"G\u00f6rar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Tekeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"706_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnose and treatment. Nat Rev Endocrinol. 2018;14:270\u201384. https:\/\/doi.org\/10.1038\/nrendo.2018.24.","journal-title":"Nat Rev Endocrinol"},{"key":"706_CR2","doi-asserted-by":"publisher","first-page":"d6407","DOI":"10.1136\/bmj.d6407","volume":"343","author":"NS Macklon","year":"2011","unstructured":"Macklon NS. Polycystic ovary syndome. BMJ. 2011;343:d6407.","journal-title":"BMJ."},{"issue":"3","key":"706_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/eje.0.1500363","volume":"150","author":"OE Janssen","year":"2004","unstructured":"Janssen OE, Mehlmauer N, Hahn S, et al. High prevalence of autoimmune thyroidits in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150(3):363\u20139.","journal-title":"Eur J Endocrinol"},{"key":"706_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fendo.2019.00222","volume":"10","author":"J Cai","year":"2019","unstructured":"Cai J, Zhang Y, Wang Y, Li S, Wang L, Zheng J, Jiang Y, Dong Y, Zhou H, Hu Y, Ma J, Liu W, Tao T. High thyroid stimulating hormone level is associated with Hyperandrogenism in Euthyroid polycystic ovary syndrome (PCOS) women, independent of age, BMI, and thyroid autoimmunity: a cross-sectional analysis. Front Endocrinol. 2019;10:222. https:\/\/doi.org\/10.3389\/fendo.2019.00222.","journal-title":"Front Endocrinol"},{"key":"706_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJM199607113350206","volume":"335","author":"CM Dayan","year":"1996","unstructured":"Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996;335:99\u2013107. https:\/\/doi.org\/10.1056\/NEJM199607113350206.","journal-title":"N Engl J Med"},{"key":"706_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/ncpendmet0846","volume":"4","author":"K Poppe","year":"2008","unstructured":"Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab. 2008;4:394\u2013405. https:\/\/doi.org\/10.1038\/ncpendmet0846.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"706_CR7","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","volume":"379","author":"DS Cooper","year":"2012","unstructured":"Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379:1142\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(11)60276-6.","journal-title":"Lancet."},{"key":"706_CR8","first-page":"215","volume":"19","author":"S Hep\u015fen","year":"2018","unstructured":"Hep\u015fen S, Karak\u00f6se M, \u00c7akal E, \u00d6ztekin S, \u00dcnsal \u0130, Akhanl\u0131 P, U\u00e7an B, \u00d6zbek M. The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome. J Turk Ger Gynecol Assoc. 2018;19:215\u20139.","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"706_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.autrev.2010.06.008","volume":"9","author":"S Dragojevic-Dikic","year":"2010","unstructured":"Dragojevic-Dikic S, Marisavljevic D, Mitrovic A, et al. An immunological insight into premature ovarian failure (POF). Autoimmun Rev. 2010;9:771\u20134.","journal-title":"Autoimmun Rev"},{"key":"706_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2265.1993.tb01748.x","volume":"39","author":"C Betterle","year":"1993","unstructured":"Betterle C, Rossi A, Dalla Pria S, et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol. 1993;39:35\u201343.","journal-title":"Clin Endocrinol"},{"key":"706_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jaut.2011.11.014","volume":"38","author":"G Twig","year":"2012","unstructured":"Twig G, Shina A, Amital H, Shoenfeld Y. Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. J Autoimmun. 2012;38:275\u201381.","journal-title":"J Autoimmun"},{"key":"706_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1089\/105072502320908330","volume":"12","author":"K Poppe","year":"2002","unstructured":"Poppe K, Glinoer D, Van Steirteghem A, Tournaye H, Devroey P, Schiettecatte J, et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid. 2002;12:997\u20131001.","journal-title":"Thyroid"},{"key":"706_CR13","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1093\/humrep\/14.11.2720","volume":"14","author":"E Kousta","year":"1999","unstructured":"Kousta E, White DM, Cela E, McCarthy MI, Franks S. The prevalence of polycystic ovaries in women with infertility. Hum Reprod. 1999;14:2720\u20133.","journal-title":"Hum Reprod"},{"key":"706_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.fertnstert.2010.10.011","volume":"95","author":"DB Seifer","year":"2011","unstructured":"Seifer DB, Baker VL, Leader B. Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95:747\u201350.","journal-title":"Fertil Steril"},{"key":"706_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","volume":"217","author":"R Tal","year":"2017","unstructured":"Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217:129\u201340.","journal-title":"Am J Obstet Gynecol"},{"key":"706_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","volume":"103","author":"R Tal","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ, Seifer DB. Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103:119\u201330 e3.","journal-title":"Fertil Steril"},{"issue":"1","key":"706_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"key":"706_CR18","first-page":"381","volume":"38","author":"CJ van Gelderen","year":"1993","unstructured":"van Gelderen CJ. Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med. 1993;38:381\u20136.","journal-title":"J Reprod Med"},{"key":"706_CR19","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.fertnstert.2009.01.056","volume":"93","author":"K Hefler-Frischmuth","year":"2010","unstructured":"Hefler-Frischmuth K, Walch K, Huebl W, Baumuehlner K, Tempfer C, Hefler L. Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril. 2010;93:2291\u20134.","journal-title":"Fertil Steril"},{"key":"706_CR20","first-page":"213","volume":"75","author":"CE Calvar","year":"2015","unstructured":"Calvar CE, Bengolea SV, Deutsch SI, Hermes R, Ramos G, Loyato M. High frequency of thyroid abnormalities in polycystic ovary syndrome. Medicina (B Aires). 2015;75:213\u20137.","journal-title":"Medicina (B Aires)"},{"key":"706_CR21","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.3390\/ijerph17072422","volume":"17","author":"CW Ho","year":"2020","unstructured":"Ho CW, Chen HH, Hsieh MC, Chen CC, Hsu SP, Yip HT, Kao CH. Increased risk of polycystic ovary syndrome and It\u2019s comorbidities in women with autoimmune thyroid disease. Int J Environ Res Public Health. 2020;17:2422. https:\/\/doi.org\/10.3390\/ijerph17072422.","journal-title":"Int J Environ Res Public Health"},{"key":"706_CR22","first-page":"880","volume":"6","author":"D Du","year":"2013","unstructured":"Du D, Li X. The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis. Int J Clin Exp Med. 2013;6:880\u20139.","journal-title":"Int J Clin Exp Med"},{"key":"706_CR23","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3109\/01443615.2010.517331","volume":"30","author":"RL Kennedy","year":"2010","unstructured":"Kennedy RL, Malabu UH, Jarrod G, Nigam P, Kannan K, Rane A. Thyroid function and pregnancy: before, during and beyond. J Obstet Gynaecol. 2010;30:774\u201383.","journal-title":"J Obstet Gynaecol"},{"key":"706_CR24","first-page":"977","volume":"19","author":"S Medenica","year":"2015","unstructured":"Medenica S, Nedeljkovic O, Radojevic N, Stojkovic M, Trbojevic B, Pajovic B. Thyroid dysfunction and thyroid autoimmunity in euthyroid women in achieving fertility. Eur Rev Med Pharmacol Sci. 2015;19:977\u201387.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"706_CR25","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/S0140-6736(99)00256-1","volume":"353","author":"P F\u00e9nichel","year":"1999","unstructured":"F\u00e9nichel P, Gobert B, Carr\u00e9 Y, et al. Polycystic ovary syndrome in autoimmune disease. Lancet. 1999;353:2210.","journal-title":"Lancet"},{"issue":"7","key":"706_CR26","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.fertnstert.2010.05.063","volume":"94","author":"J Ott","year":"2010","unstructured":"Ott J, Aust S, Kurz C, Nouri K, Wirth S, Huber JC, et al. Elevated antithyroid peroxidase antibodies indicating Hashimoto's thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome. Fertil Steril. 2010;94(7):2895\u20137.","journal-title":"Fertil Steril"},{"issue":"2","key":"706_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1600-0897.2010.00961.x","volume":"66","author":"P Monteleone","year":"2011","unstructured":"Monteleone P, Parrini D, Faviana P, Carletti E, Casarosa E, Uccelli A, et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol. 2011;66(2):108\u201314.","journal-title":"Am J Reprod Immunol"},{"key":"706_CR28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/humrep\/dem383","volume":"23","author":"J Bellver","year":"2008","unstructured":"Bellver J, Soares SR, Alvarez C, Mu\u00f1oz E, Ram\u00edrez A, Rubio C, et al. The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod. 2008;23:278\u201384.","journal-title":"Hum Reprod"},{"key":"706_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12902-019-0370-7","volume":"19","author":"S Bahri","year":"2019","unstructured":"Bahri S, Tehrani FR, Amouzgar A, Rahmati M, Tohidi M, Vasheghani M, Azizi F. Overtime trend of thyroid hormones and thyroid autoimmunity and ovarian reserve: a longitudinal population study with a 12- year follow up. BMC Endocr Disord. 2019;19:47. https:\/\/doi.org\/10.1186\/s12902-019-0370-7.","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"706_CR30","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1089\/thy.2017.0139","volume":"27","author":"C-W Chen","year":"2017","unstructured":"Chen C-W, Huang Y-L, Tzeng C-R, Huang R-L, Chen C-H. Idiopathic low ovarian reserve is associated with more frequent positive thyroid peroxidase antibodies. Thyroid. 2017;27(9):1194\u2013200.","journal-title":"Thyroid."},{"issue":"2","key":"706_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/09513590.2014.973391","volume":"31","author":"F Saglam","year":"2015","unstructured":"Saglam F, Onal ED, Ersoy R, Koca C, Ergin M, Erel O, et al. Anti-M\u00fcllerian hormone as a marker of premature ovarian aging in autoimmune thyroid disease. Gynecol Endocrinol. 2015;31(2):165\u20138.","journal-title":"Gynecol Endocrinol"},{"key":"706_CR32","first-page":"27","volume":"66","author":"MM Alper","year":"1985","unstructured":"Alper MM, Garner PR. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol. 1985;66:27\u201330.","journal-title":"Obstet Gynecol"},{"key":"706_CR33","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/BF03348951","volume":"16","author":"L Belvisi","year":"1993","unstructured":"Belvisi L, Bombelli F, Sironi L, Doldi N. Organ-specific autoimmunity in patients with premature ovarian failure. J Endocrinol Investig. 1993;16:889\u201392.","journal-title":"J Endocrinol Investig"},{"key":"706_CR34","first-page":"281","volume":"7","author":"R Kosir Pogacnik","year":"2014","unstructured":"Kosir Pogacnik R, Meden Vrtovec H, Vizjak A, et al. Possible role of autoimmunity in patients with premature ovarian insufficiency. Int J Fertil Steril. 2014;7:281\u201390.","journal-title":"Int J Fertil Steril"},{"key":"706_CR35","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1210\/jc.2006-1005","volume":"91","author":"R Goswami","year":"2006","unstructured":"Goswami R, Marwaha RK, Goswami D, Gupta N, Ray D, Tomar N, Singh S. Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab. 2006;91:4256\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejogrb.2016.06.002","volume":"203","author":"O Erol","year":"2016","unstructured":"Erol O, Parlak M, Ellidag HY, Parlak AE, Derbent AU, Eren E, Y\u0131lmaz N. Serum anti-Mullerian hormone levels in euthyroid adolescent girls with Hashimoto's thyroiditis: relationship to antioxidant status. Eur J Obstet Gynecol Reprod Biol. 2016;203:204\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"706_CR37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3109\/09513590.2015.1116510","volume":"32","author":"O Pirgon","year":"2016","unstructured":"Pirgon O, Sivrice C, Demirtas H, Dundar B. Assessment of ovarian reserve in euthyroid adolescents with Hashimoto\u2019s thyroiditis. Gynecol Endocrinol. 2016;32:306\u201310.","journal-title":"Gynecol Endocrinol"},{"key":"706_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.autrev.2007.06.001","volume":"7","author":"G Norbert","year":"2007","unstructured":"Norbert G, David B, Andrea W. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev. 2007;7:42\u20135.","journal-title":"Autoimmun Rev"},{"key":"706_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10815-013-9974-4","volume":"30","author":"NN Shamilova","year":"2013","unstructured":"Shamilova NN, Marchenko LA, Dolgushina NV, et al. The role of genetic and autoimmune factors in premature ovarian failure. J Assist Reprod Genet. 2013;30:617\u201322.","journal-title":"J Assist Reprod Genet"},{"key":"706_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1586\/17474108.2.4.465","volume":"2","author":"N Gleicher","year":"2007","unstructured":"Gleicher N, Weghofer A, Barad D. Female infertility due to abnormal autoimmunity: frequently overlooked and greatly underappreciated. Expert Rev Obstet Gynecol. 2007;2:465\u201375.","journal-title":"Expert Rev Obstet Gynecol"},{"key":"706_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12958-015-0103-3","volume":"13","author":"F Magri","year":"2015","unstructured":"Magri F, Schena L, Capelli V, Gaiti M, Zerbini F, Brambilla E, Rotondi M, De Amici M, Spinillo A, Nappi RE, Chiovato L. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity. Reprod Biol Endocrinol. 2015;13:106.","journal-title":"Reprod Biol Endocrinol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-021-00706-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T03:03:10Z","timestamp":1615258990000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-021-00706-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1186\/s12902-021-00706-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants signed written informed consent forms and the study was approved by the Ethical Review Committee (ERC) of Antalya Training and Research Hospital, Antalya, Turkey (Ethics Committee Decision Date - No: 05.05.2016\u20139\/11).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflict of interest was reported by the author(s). The authors alone are responsible for the content and writing of the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}